PKD1 and cardiac hypertrophy: Moreover, these beneficial effects of MI14 can be extended to other cardiomyocyte models of hypertrophy than PE stimulation, as MI14 also successfully inhibited the maladaptive increases in glucose uptake in cardiomyocytes with PKD1 overexpression, another model of cardiac hypertrophy [17].